20.Jan.2009

OCT has been chosen to conduct hypertension plus LVH study

OCT has been chosen to conduct hypertension plus LVH study for Menarini Group, 62 patients already enrolled, and hepatic cirrhosis study with 19 sites for the UK Pharma.
OCT has been chosen to conduct hypertension plus LVH study for Menarini Group, 62 patients already enrolled, and hepatic cirrhosis study with 19 sites for the UK Pharma.